These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14658047)

  • 1. Anti-annexin V antibodies in the cerebrospinal fluid and serum of patients with amyotrophic lateral sclerosis.
    Iłzecka J; Stelmasiak Z
    Neurol Sci; 2003 Nov; 24(4):273-4. PubMed ID: 14658047
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis.
    Nociti V; Frisullo G; Marti A; Luigetti M; Iorio R; Patanella AK; Bianco A; Tonali PA; Grillo RL; Sabatelli M; Batocchi AP
    J Neuroimmunol; 2010 Aug; 225(1-2):149-52. PubMed ID: 20510468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyotrophic lateral sclerosis an enigmatic disease with B-cellular and anti-retroviral immune responses.
    Westarp ME; Fuchs D; Bartmann P; Hoff-Jörgensen R; Clausen J; Wachter H; Kornhuber HH
    Eur J Med; 1993; 2(6):327-32. PubMed ID: 8252177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D
    Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-annexin V antibodies and digital ischemia in patients with scleroderma.
    Sugiura K; Muro Y
    J Rheumatol; 1999 Oct; 26(10):2168-72. PubMed ID: 10529134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Jiménez-Jiménez FJ; Hernánz A; Medina-Acebrón S; de Bustos F; Zurdo JM; Alonso H; Puertas I; Barcenilla B; Sayed Y; Cabrera-Valdivia F
    Acta Neurol Scand; 2005 Feb; 111(2):114-7. PubMed ID: 15644071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyme disease serology in amyotrophic lateral sclerosis.
    Qureshi M; Bedlack RS; Cudkowicz ME
    Muscle Nerve; 2009 Oct; 40(4):626-8. PubMed ID: 19697382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sCD30, interleukin-1beta-converting enzyme and anti-Annexin V autoantibodies concentrations in heart transplant recipients.
    Zeglen S; Zakliczyński M; Nozyński J; Rogala B; Zembala M
    Transpl Immunol; 2006 Nov; 16(3-4):227-31. PubMed ID: 17138058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis.
    Fialová L; Svarcová J; Bartos A; Ridzon P; Malbohan I; Keller O; Rusina R
    Eur J Neurol; 2010 Apr; 17(4):562-6. PubMed ID: 19968709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibodies to the structural elements of the neuron in patients with amyotrophic lateral sclerosis and in their healthy relatives].
    Zavalishin IA; Roĭkhel' VM; Fokina GI; Kozlovskiĭ AD; Pogodina VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(3):12-5. PubMed ID: 1646524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-12 and interferon-gamma are not detectable in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ford L; Rowe D
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):118-20. PubMed ID: 15204013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kaufmann E; Boehm BO; Süssmuth SD; Kientsch-Engel R; Sperfeld A; Ludolph AC; Tumani H
    Neurosci Lett; 2004 Nov; 371(2-3):226-9. PubMed ID: 15519762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amyotrophic lateral sclerosis and anti-CV2 antibodies. Paraneoplastic association?].
    García Martín G; Perez Errazquin F; Chamorro Muñoz M; Romero Acebal M
    Neurologia; 2007; 22(6):406-9. PubMed ID: 17610172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2008 May; 117(5):343-6. PubMed ID: 17995989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of 1038 pregnancies on the predictive value of anti-annexin V antibodies for fetal loss.
    Bizzaro N; Antico A; Musso M; Platzgummer S; Camogliano L; Tozzoli R; Villalta D
    Ann N Y Acad Sci; 2005 Jun; 1050():348-56. PubMed ID: 16014551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Clin Neurol Neurosurg; 2004 Sep; 106(4):289-93. PubMed ID: 15297002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.